Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Ensuring Compliance with GMP in Machine Operations – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Ensuring Compliance with GMP in Machine Operations – V 2.0

Standard Operating Procedure for Ensuring Compliance with GMP in Machine Operations


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/146/2025
Supersedes SOP/SIM/146/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To establish a standardized procedure for ensuring compliance with Good Manufacturing Practices (GMP) during all phases of machine operations in sterile injectable manufacturing, including setup, running, cleaning, maintenance, and documentation.

2. Scope

This SOP

applies to all personnel involved in the operation of sterile injectable manufacturing equipment, including vial washing machines, filling lines, lyophilizers, sealing stations, and packaging machinery within the classified cleanroom areas.

3. Responsibilities

  • Machine Operators: Ensure GMP practices are followed during setup, operation, and shutdown of equipment.
  • Supervisors: Verify operator compliance, perform routine checks, and escalate non-compliance.
  • QA Personnel: Perform periodic audits and approve batch and cleaning records.

4. Accountability

The Head of Production is accountable for enforcing GMP standards. The Head of Quality Assurance is accountable for ensuring audits and compliance reviews are conducted and documented.

See also  Sterile Injection Manufacturing: SOP for Ensuring Tamper-Evident Sealing on Syringe Packs - V 2.0

5. Procedure

5.1 GMP Requirements for Machine Operation

  1. Ensure machine area is classified and meets environmental conditions as per batch requirement (Grade A/B/C).
  2. Use cleanroom garments and PPE as per gowning SOP before operating any machine.
  3. Pre-inspect machines for cleanliness, absence of contaminants, and verify completion of cleaning and maintenance logs.

5.2 Equipment Setup and Line Clearance

  1. Perform line clearance using the Line Clearance Checklist (Annexure-1).
  2. Ensure all previous product remnants, documents, and labels are removed from the area.
  3. QA must verify and sign off the line clearance before production start.

5.3 Equipment Operation and Monitoring

  1. Operate machines as per respective machine SOPs and validated parameters.
  2. Record operational parameters such as speed, temperature, filling volume, and vacuum levels in the Machine Operation Log (Annexure-2).
  3. Report any abnormal sound, fluctuation, or malfunction to the supervisor immediately.

5.4 Equipment Cleaning and Sanitization

  1. Clean machines before and after each batch, or as per defined frequency.
  2. Use validated cleaning agents only.
  3. Record cleaning activities in the Equipment Cleaning Log (Annexure-3).
See also  Sterile Injectable Manufacturing: SOP for Ensuring No Residue Post-Cleaning of Machines - V 2.0

5.5 Preventive Maintenance and Calibration

  1. Conduct preventive maintenance as per the PM schedule.
  2. Ensure all critical instruments (temperature gauges, timers, sensors) are calibrated and not expired.
  3. Attach calibration sticker on each calibrated component.

5.6 Documentation Practices

  1. Fill all logbooks in indelible ink. Do not leave blanks.
  2. Correct errors by striking a single line, signing, and dating.
  3. Follow ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate).

5.7 GMP Non-Compliance Handling

  1. Any observed non-compliance must be documented in a Deviation Report (Annexure-4).
  2. Initiate investigation and risk assessment with QA support.
  3. Implement CAPA and monitor effectiveness over time.

5.8 Training Requirements

  1. All machine operators must be trained annually on GMP principles and this SOP.
  2. Training attendance and evaluation must be recorded in the Training Record Sheet (Annexure-5).

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • PM: Preventive Maintenance
  • SOP: Standard Operating Procedure
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Line Clearance Checklist – Annexure-1
  2. Machine Operation Log – Annexure-2
  3. Equipment Cleaning Log – Annexure-3
  4. Deviation Report – Annexure-4
  5. Training Record Sheet – Annexure-5

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
  • EU GMP Guidelines Annex 1 (2022 Revision)
See also  Sterile Injectable Manufacturing: SOP for Handling Deviations in Manufacturing Stages - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Line Clearance Checklist

Item Status Remarks Checked By
Previous labels removed Yes NA Sunil Sharma

Annexure-2: Machine Operation Log

Date Machine Parameter Value Operator
24/06/2025 Filler-01 Speed 180 bpm Ravi Mehra

Annexure-3: Equipment Cleaning Log

Date Machine Cleaning Type Performed By Verified By
24/06/2025 Vial Sealer Post-batch Asha Patel QA Officer

Annexure-4: Deviation Report

Date Deviation Root Cause CAPA Closure Date
22/06/2025 Wrong speed setting Operator error Retraining 23/06/2025

Annexure-5: Training Record Sheet

Employee Name Date Trainer Topic Remarks
Manoj Nair 15/06/2025 QA Manager GMP for Machine Use Passed

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Incorporated Annexures and GMP audit clauses Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Checklist for Reviewing SOP Drafts Before Approval
Next Post: Gel Manufacturing: SOP for Line Clearance Before Gel Production – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version